Literature DB >> 28483601

RCTS are the only appropriate way to demonstrate the role of vitamin D in health.

Rolf Jorde1.   

Abstract

Despite thousands of vitamin D studies published, including hundreds of reviews and meta-analyses, it is still uncertain if supplementation with vitamin D will have positive health effects, except for the skeleton. This cannot be answered by doing more observational studies as it is impossible to control for confounding factors and reverse causality. The only way to firmly prove positive vitamin D effects is by doing the properly designed randomized controlled trials (RCTs). However, it has been difficult to show the expected positive effects by vitamin D supplementation in RCTs, which may indicate that the effects, if present must be small. On the other hand, results from Mendelian randomization studies have shown promising results at least for mortality and multiple sclerosis. In the near future, results from several large RCTs with hard endpoints will be available. If these show positive results, the main question on vitamin D and health is answered. If they turn out negative, they will be criticized for having included subjects without vitamin D deficiency, and some studies might not have used an optimal dosing regimen. New and better-designed RCTs will then be needed, but will be very hard to perform.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mendelian randomization; Observational trials; Randomized controlled trials; Reverse causality; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28483601     DOI: 10.1016/j.jsbmb.2017.05.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  6 in total

Review 1.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Authors:  Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

2.  Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial.

Authors:  Armin Zittermann; Jana B Ernst; Sylvana Prokop; Uwe Fuchs; Jens Dreier; Joachim Kuhn; Cornelius Knabbe; Heiner K Berthold; Ioanna Gouni-Berthold; Jan F Gummert; Jochen Börgermann; Stefan Pilz
Journal:  Eur J Nutr       Date:  2018-03-15       Impact factor: 5.614

Review 3.  The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes.

Authors:  Rolf Jorde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-19       Impact factor: 5.555

Review 4.  An Update on Vitamin D and Disease Activity in Multiple Sclerosis.

Authors:  Joost Smolders; Øivind Torkildsen; William Camu; Trygve Holmøy
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

5.  What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMJ Open       Date:  2018-01-13       Impact factor: 2.692

6.  Sun Exposure across the Life Course Significantly Modulates Early Multiple Sclerosis Clinical Course.

Authors:  Steve Simpson; Ingrid van der Mei; Robyn M Lucas; Anne-Louise Ponsonby; Simon Broadley; Leigh Blizzard; Bruce Taylor
Journal:  Front Neurol       Date:  2018-02-01       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.